Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.25 USD | +0.61% | +12.24% | +26.92% |
30/04 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
29/04 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Mammalian Cell Culture
84.0
%
| 99 | 83.0 % | 125 | 84.0 % | +26.32% |
Process Development
16.0
%
| 20 | 17.0 % | 24 | 16.0 % | +17.40% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 120 | 100.0 % | 149 | 100.0 % | +24.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 30/20/30 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 01/18/01 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 01/99/01 |
Richard Richieri
COO | Chief Operating Officer | 59 | 09/19/09 |
Richard Hancock
BRD | Director/Board Member | 65 | 27/17/27 |
Oksana Lukash
HRO | Human Resources Officer | - | 16/22/16 |
Michael Alston
PRN | Corporate Officer/Principal | - | 01/19/01 |
Michael Faughnan
PRN | Corporate Officer/Principal | - | - |
Elie Hanania
PRN | Corporate Officer/Principal | - | 04/21/04 |
Corporate Officer/Principal | - | 07/21/07 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 27/17/27 |
Joseph Carleone
CHM | Chairman | 78 | 27/17/27 |
Catherine Mackey
BRD | Director/Board Member | 68 | 25/19/25 |
Nicholas Green
CEO | Chief Executive Officer | 60 | 30/20/30 |
Esther Alegria
BRD | Director/Board Member | 66 | 28/21/28 |
Jeanne A. Thoma
BRD | Director/Board Member | 64 | 03/20/03 |
Richard Hancock
BRD | Director/Board Member | 65 | 27/17/27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,479,794 | 62,781,178 ( 98.90 %) | 0 | 98.90 % |
Company contact information
Sector
Sales per Business
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.92% | 524M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-14.38% | 12.07B | |
-9.12% | 11.97B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- CDMO Stock
- Company Avid Bioservices, Inc.